Opportunity Information: Apply for RFA MH 14 211
Apply for RFA MH 14 211
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants.
- This funding opportunity was created on Aug 7, 2013 and posted on Aug 7, 2013.
- Applicants must submit their applications by Jan 6, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Private institutions of higher education Small businesses State governments Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) County governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Independent school districts Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This National Institutes of Health (NIH) funding opportunity, titled "Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R01)" (Funding Opportunity Number RFA-MH-14-211), supports research focused on early intervention for people who are considered at clinical high risk for developing psychotic disorders. The central idea behind the announcement is that psychotic illnesses can be profoundly disruptive and disabling, and that intervening earlier, before a first full psychotic episode, may help prevent or delay the onset of psychosis while also reducing other common and damaging outcomes. These broader outcomes include mood problems, substance use disorders, and declines in real-world functioning such as social relationships, school performance, and employment or vocational progress. In other words, the opportunity is not only about stopping psychosis, but also about improving day-to-day functioning and quality of life for individuals who are already showing clinically meaningful warning signs.
A major emphasis of the announcement is building evidence that can guide a stepwise, or "stepped care," approach to early psychosis intervention in the United States. Stepped care generally means matching people to the least intensive, most appropriate intervention first, then adjusting and intensifying care as needed based on response, symptom progression, and functional impairment. To move that model forward, NIH is seeking rigorous studies that test whether specific interventions actually help with both symptoms and functioning in clinical risk states. The FOA encourages applications that evaluate the effectiveness of interventions aimed at the kinds of difficulties that often appear during the high-risk period, including attenuated psychotic symptoms, distress, cognitive or social challenges, and problems maintaining roles in school or work.
Beyond testing whether an intervention works, the announcement also explicitly calls for studies that examine how and why an intervention works. That means proposals are encouraged to test hypotheses about mediators and mechanisms of action, such as whether an intervention reduces stress sensitivity, improves coping, strengthens social cognition, alters sleep patterns, reduces substance use, or changes other measurable processes that could explain improvements in symptoms or functioning. By identifying mechanisms, the research can do more than produce a single positive trial; it can help refine treatments, identify who is most likely to benefit, and inform smarter, more personalized stepped care pathways.
Another key goal is practicality and real-world impact. NIH highlights the importance of determining whether these approaches can be implemented in community-based treatment settings, not just in highly specialized academic clinics. This includes studying feasibility issues such as recruitment and retention of high-risk youth and young adults, clinician training demands, acceptability to participants and families, costs and staffing constraints, and whether community programs can deliver interventions with fidelity. The underlying aim is to generate evidence that can translate into routine practice, making early intervention more accessible and scalable.
Administratively, this is a discretionary grant opportunity using the NIH R01 research project grant mechanism, falling under the health funding activity category and associated with CFDA 93.242 (Mental Health Research Grants). The announcement was posted August 7, 2013, with an original and current closing date of January 6, 2014, and an archive date of February 6, 2014. NIH listed an estimated total funding amount of $5,000,000 for this opportunity and specified that cost sharing or matching is not required. While the announcement itself is archived, the details illustrate NIH priorities in early psychosis prevention research and the kind of evidence base NIH has sought to build for stepped care models.
Eligibility is broad and includes many types of U.S.-based organizations and several non-U.S. applicants as well. Eligible applicants include private and public institutions of higher education, state and local governments (including counties, cities/townships, special districts, and independent school districts), small businesses, other for-profit organizations (excluding small businesses where noted), public housing authorities/Indian housing authorities, and nonprofits both with and without 501(c)(3) status (with distinctions depending on whether they are institutions of higher education). The FOA also explicitly includes a wide range of special categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs). Faith-based and community-based organizations are eligible, as are eligible federal agencies. Importantly, non-domestic entities (foreign organizations and foreign institutions) may apply, and foreign components of U.S. organizations are allowed as defined in the NIH Grants Policy Statement.
Overall, the opportunity is designed to push the field toward evidence-driven early intervention for clinical high risk states by funding studies that (1) evaluate interventions for symptom and functional problems, (2) clarify mechanisms and mediators, (3) produce results that can inform stepped care systems, and (4) test whether these strategies are feasible and workable in community settings where most people actually receive care.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this NIH grant?
The opportunity is titled "Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R01)" and the Funding Opportunity Number is RFA-MH-14-211.
What is the overall purpose of this funding opportunity?
This NIH opportunity supports research on early intervention for people who are at clinical high risk for developing psychotic disorders. The goal is to generate evidence that earlier intervention, before a first full psychotic episode, may help prevent or delay psychosis and also reduce other harmful outcomes that commonly occur during the high-risk period.
Is the focus only on preventing psychosis?
No. While preventing or delaying the onset of psychosis is central, the opportunity also emphasizes improving other clinically important outcomes, including mood problems, substance use disorders, and declines in real-world functioning (such as social relationships, school performance, and employment or vocational progress).
Who is the population of interest for the research?
The research is focused on individuals considered at clinical high risk for developing psychotic disorders, including youth and young adults who show clinically meaningful warning signs prior to a first full psychotic episode.
What kinds of interventions does NIH want studied under this FOA?
The FOA encourages rigorous studies that evaluate the effectiveness of interventions aimed at difficulties often present during the high-risk period. Examples of targets include attenuated psychotic symptoms, distress, cognitive or social challenges, and problems maintaining roles in school or work.
What does "stepped care" mean in the context of this opportunity?
Stepped care refers to a stepwise approach where individuals start with the least intensive, most appropriate intervention, and care is adjusted or intensified based on factors like response, symptom progression, and functional impairment. The FOA places major emphasis on building an evidence base that can guide stepped care models for early psychosis intervention in the United States.
Does the FOA emphasize understanding how interventions work (not just whether they work)?
Yes. In addition to testing outcomes, the FOA explicitly calls for studies that examine mediators and mechanisms of action to understand how and why an intervention produces changes in symptoms and functioning.
What are examples of mechanisms or mediators that applications might examine?
The FOA mentions hypotheses such as whether an intervention reduces stress sensitivity, improves coping, strengthens social cognition, alters sleep patterns, reduces substance use, or changes other measurable processes that could explain improvements in symptoms or functioning.
Why does NIH emphasize mechanisms and mediators in this research area?
Identifying mechanisms can help refine treatments, support more personalized decision-making, and indicate who is most likely to benefit. This can strengthen stepped care pathways by informing smarter matching of individuals to interventions and helping determine when and how to adjust care.
Is community-based implementation part of what NIH is looking for?
Yes. NIH highlights the importance of determining whether these approaches can be implemented in community-based treatment settings, not only in specialized academic clinics, to increase real-world impact and scalability.
What kinds of real-world or feasibility issues does the FOA encourage researchers to address?
The FOA points to practical considerations such as recruitment and retention of high-risk youth and young adults, clinician training demands, acceptability to participants and families, costs and staffing constraints, and the ability of community programs to deliver interventions with fidelity.
What grant mechanism is used for this opportunity?
This is an NIH R01 research project grant opportunity.
What is the CFDA number and program area associated with this funding?
The FOA is associated with CFDA 93.242, Mental Health Research Grants, and falls under the health funding activity category.
How much total funding did NIH estimate for this opportunity?
NIH listed an estimated total funding amount of $5,000,000 for this opportunity.
Is cost sharing or matching required?
No. The FOA specifies that cost sharing or matching is not required.
When was the FOA posted, and what were the closing and archive dates?
The announcement was posted on August 7, 2013. The original and current closing date was January 6, 2014, and the archive date was February 6, 2014.
Is this funding opportunity still active?
No. The FOA is archived (archive date: February 6, 2014). The content still illustrates NIH priorities for building evidence on early intervention and stepped care approaches for clinical high risk states.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and certain non-U.S. applicants. Eligible applicants include private and public institutions of higher education; state and local governments (including counties, cities/townships, special districts, and independent school districts); small businesses; other for-profit organizations (excluding small businesses where noted); public housing authorities/Indian housing authorities; and nonprofits with or without 501(c)(3) status (with distinctions depending on whether they are institutions of higher education).
Are minority-serving institutions specifically included as eligible applicants?
Yes. The FOA explicitly includes categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations are listed as eligible applicants.
Are federal agencies eligible to apply?
Yes. The FOA states that eligible federal agencies may apply.
Can non-U.S. (foreign) organizations apply?
Yes. The FOA states that non-domestic entities (foreign organizations and foreign institutions) may apply.
Are foreign components of U.S. organizations allowed?
Yes. Foreign components of U.S. organizations are allowed as defined in the NIH Grants Policy Statement.
What are the main research priorities emphasized by the FOA?
The FOA is designed to advance evidence-driven early intervention for clinical high risk states by supporting studies that: (1) evaluate interventions for symptom and functional problems, (2) clarify mechanisms and mediators, (3) produce results that can inform stepped care systems, and (4) assess feasibility and practicality in community settings.
Browse more opportunities from the same category: Health
Next opportunity: Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R34)
Previous opportunity: Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (Collaborative R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 14 211
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 14 211) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R34) Apply for RFA MH 14 212 Funding Number: RFA MH 14 212 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| PPHF 2013 Immunization Increasing Human Papillomavirus (HPV) Vaccination Coverage Rates among Adolescents financed solely by 2013 Prevention and Public Health Funds Apply for CDC RFA IP13 130101PPHF13 Funding Number: CDC RFA IP13 130101PPHF13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Methods for Prevention Packages Program III (MP3 III) (R01) Apply for PAR 13 322 Funding Number: PAR 13 322 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| IIS Sentinel Site Pandemic Preparedness and Response Planning Apply for CDC RFA IP13 130201SUPP13 Funding Number: CDC RFA IP13 130201SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| 2014 NIH Pioneer Award Program (DP1) Apply for RFA RM 13 006 Funding Number: RFA RM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| 2014 NIH Directors New Innovator Award Program (DP2) Apply for RFA RM 13 007 Funding Number: RFA RM 13 007 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Limited Pilot for NIGMS Legacy Community Wide Scientific Resources (R24) Apply for PAR 13 324 Funding Number: PAR 13 324 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 14 010 Funding Number: RFA AG 14 010 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| NIA Revision and Resubmission Program Project Applications (P01) Apply for PAR 13 329 Funding Number: PAR 13 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Audacious Goals Initiative High Priority Research Area Intersection of Aging and Biological Mechanisms of Eye Disease (R01) Apply for PA 13 332 Funding Number: PA 13 332 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Bridges to Baccalaureate Program (R25) Apply for PAR 13 333 Funding Number: PAR 13 333 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| State and Regional Primary Care Association (PCA) Cooperative Agreements for Alaska, Georgia, and Wyoming Apply for HRSA 14 032 Funding Number: HRSA 14 032 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Indian Health Outreach and Education II Apply for HHS 2013 IHS NIHOE 0002 Funding Number: HHS 2013 IHS NIHOE 0002 Agency: Indian Health Service Category: Health Funding Amount: $150,000 |
| NIH Directors Early Independence Awards (DP5) Apply for RFA RM 13 009 Funding Number: RFA RM 13 009 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point of Care SBIR (R43/R44) Apply for RFA HL 14 011 Funding Number: RFA HL 14 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point of Care STTR (R41/R42) Apply for RFA HL 14 017 Funding Number: RFA HL 14 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (Round Mountain, CA and Cheyenne, WY) Apply for HRSA 14 100 Funding Number: HRSA 14 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Smallpox Research Oversight Activities Apply for EP IDS 13 003 Funding Number: EP IDS 13 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $290,000 |
| Library of Integrated Network Based Cellular Signatures (LINCS) Perturbation Induced Data and Signature Generation Centers (U54) Apply for RFA RM 13 013 Funding Number: RFA RM 13 013 Agency: National Institutes of Health Category: Health Funding Amount: $1,700,000 |
| State Vital Statistics Improvement Program Apply for CDC RFA SH12 12010203SUPP13 Funding Number: CDC RFA SH12 12010203SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $110,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 14 211", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
